Announcements Trials
Browse Landscape

Phase

Phase 2 204Phase 1 99Phase 3 35Phase 1/2 30Phase NA 17Phase EARLY_PHASE1 8Phase 2/3 4Phase 4 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 77INDUSTRY 18OTHER_GOV 5NIH 2UNKNOWN 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Classical hematology 2Breast 2Tumor-Agnostic 1Sarcoma 1Lymphoid 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Human Papillomavirus-Related Cervical Carcinoma 1Anemia 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1epoetin beta 1adacel 1Tetanus Toxoid 1Radiotherapy 1Human Papillomavirus Recombinant Vaccine nonavalent 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Cisplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × NIH × Gynecologic × Clear all
NCT05237947 2026-05-22

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡